# About CJC-1295 Script: An Independent Research Console on the Literature

> CJC-1295 Script is an independent editorial project that summarizes the peer-reviewed research on CJC-1295. Not a clinic, not a pharmacy, not a vendor — a cited read-out of the published science.

An independent editorial project that reads the published CJC-1295 literature and renders it as a cited, plain-language brief. The name is a register, not a service.

## What CJC-1295 Script is

CJC-1295 Script is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site is built as a research console: a structured read-out of what the published studies measured, organized so a reader — or a machine — can find the GH and IGF-1 numbers, the DAC-versus-no-DAC half-life split, and the ipamorelin synergy rationale quickly, each tagged by evidence strength and linked to its source. Every quantitative statement on the site resolves to a numbered citation on the references page.

## What the name means

The word "Script" here is a software and console register — a generated brief, a research read-out — not a prescription pad and not a pharmacy checkout. We do not write prescriptions, fill them, or facilitate access to any compound. CJC-1295 is an unapproved research chemical, and this site neither sells it nor tells anyone how to obtain it.

We chose the console framing because the CJC-1295 literature is unusually signal-shaped: a sustained stimulus that raises a baseline while leaving a rhythm intact, a long decay curve against a short one. Rendering that as a clean, cited read-out is the most honest way we found to present it. The editorial position the name implies is a stance toward the literature, not a claim about services we provide.

## How we handle evidence

We lead with what was measured and attribute it to the study that measured it. Human pharmacokinetic findings, preclinical animal and in-vitro data, and honest gaps are labeled distinctly, so the strength of each datum is visible at a glance. When the published record runs out — as it does on long-term safety and on body-composition outcomes — we say so plainly rather than filling the gap with forum claims.

We do not recommend doses for humans, we describe what was administered to which species at which dose by which route. We use only generic compound names. And we keep the regulatory facts current: CJC-1295 is not FDA-approved, was not recommended for the 503A compounding bulks list at the 2024 Pharmacy Compounding Advisory Committee, and is prohibited at all times in sport under WADA Section S2.

---

A research console that reads the published CJC-1295 record straight — basal GH, IGF-1, and the DAC-versus-no-DAC half-life logged to source and tagged by evidence strength, with no clinic behind the console and no script filled here.